Diabetologia · 2025
High incidence of eating disorders in individuals with type 2 diabetes and their association with cardiovascular and mortality risks.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cho So Hyun, Kim Seohyun, Oh Rosa, Kim Ji Yoon, Jang Myunghwa, Lee You-Bin, Jin Sang-Man, Hur Kyu Yeon, Kim Gyuri, Kim Jae Hyeon
Аннотация
AIMS/HYPOTHESIS: We examined the incidence of eating disorders (ED) in individuals with type 2 diabetes and their impact on all-cause mortality, composite CVD, cardiovascular (CV)-related mortality and CV-related hospitalisation.
METHODS: This nationwide retrospective cohort study included 1,896,493 adults aged 20 years or older who underwent health examinations between 2013 and 2014. Time-varying Cox analyses were used to evaluate the effects of ED on all-cause mortality, composite CVD, CV-related mortality and CV-related hospitalisation in individuals with type 2 diabetes.
RESULTS: The type 2 diabetes group demonstrated an increased incidence of ED (adjusted HR [aHR] 1.20 [95% CI 1.12, 1.28]) compared with the general population. Furthermore, the incidence of ED was higher among insulin users (aHR 1.30 [1.09, 1.54]) than among non-insulin users (aHR 1.18 [1.11, 1.27]). The type 2 diabetes with ED group showed an increased rate of all-cause mortality (aHR 2.57 [2.30, 2.87]), composite CVD (aHR 1.68 [1.44, 1.96]), CV-related mortality (aHR 2.68 [1.94, 3.70]), and CV-related hospitalisation (aHR 1.61 [1.37, 1.89]).
CONCLUSIONS/INTERPRETATION: Type 2 diabetes mellitus and ED increased all-cause mortality, composite CVD, CV-related mortality and CV-related hospitalisation. ED incidence was higher among insulin users with type 2 diabetes. Therefore, early diagnosis and personalised interventions are crucial to improve outcomes in this high-risk population.
METHODS: This nationwide retrospective cohort study included 1,896,493 adults aged 20 years or older who underwent health examinations between 2013 and 2014. Time-varying Cox analyses were used to evaluate the effects of ED on all-cause mortality, composite CVD, CV-related mortality and CV-related hospitalisation in individuals with type 2 diabetes.
RESULTS: The type 2 diabetes group demonstrated an increased incidence of ED (adjusted HR [aHR] 1.20 [95% CI 1.12, 1.28]) compared with the general population. Furthermore, the incidence of ED was higher among insulin users (aHR 1.30 [1.09, 1.54]) than among non-insulin users (aHR 1.18 [1.11, 1.27]). The type 2 diabetes with ED group showed an increased rate of all-cause mortality (aHR 2.57 [2.30, 2.87]), composite CVD (aHR 1.68 [1.44, 1.96]), CV-related mortality (aHR 2.68 [1.94, 3.70]), and CV-related hospitalisation (aHR 1.61 [1.37, 1.89]).
CONCLUSIONS/INTERPRETATION: Type 2 diabetes mellitus and ED increased all-cause mortality, composite CVD, CV-related mortality and CV-related hospitalisation. ED incidence was higher among insulin users with type 2 diabetes. Therefore, early diagnosis and personalised interventions are crucial to improve outcomes in this high-risk population.